Market Comment
General Index
reverted to a downward course on Tuesday, ending at 1,195.96 points after
shedding 1.43 percent from Monday’s 1,213.31 points. The drop was
attributed to investor concerns regarding the October ECB stress test while a
second round of profit taking was witnessed in several industrial large caps.
A bounce is likely
in the beginning of the session while the banking sector remains in the
spotlight defining general trend for the day. After market hours Sarantis and
Hellenic Petroleum announce their Q2 results while investors will also look
for FED’s announcement.
Greece/PPI: The producer’s
price composite index in the industrial sector (measuring both the domestic
and external markets) rose by 1.1 pct in June, compared with the same month
last year, after an increase of 0.6 pct recorded in June 2013, Hellenic
Statistical Authority said on Tuesday. This development is attributed to a
1.5 pct increase in the domestic market producer price index and a 0.5 pct
decline in the external market index. The producer price index rose 0.4 pct
in June from May after a 0.1 pct decline recorded in the corresponding period
last year.
Greece/Privatizations: HRADF
(Greek state asset development fund) announced the winning bids for two
properties in Afantou, Rhodes:
¡
M.A. Angeliades for Golf-North Afantou at
EUR26.9m
¡ T.N.
Aegean Sun Investments for South Afantou property at EUR15.2m (improved offer
vs original bid).
The two properties cover 161.5 hectares, 136 and 25.5
respectively, of which 53 belong to a golf course which will be upgraded for
50 years down the line. Constructed buildings will not exceed 151,000 square
metres. In other news, HRADF also approved the final draft of the leasing
contract on regional airports.
Hellenic Petroleum (Results H1 2014):
Hellenic Petroleum will report its 2Q 2014 results
today after market close. Focus will be mainly to med distilling
margins evolution, debt, Elefsina restart and any developments regarding
DEPA sale. Consensus expects Adj. Q2 EBITDA
€55.2m while adj. Net earnings (loss)
will land at €-27.3m and on a reported basis €61m EBITDA and
€-24m net earnings (loss) on
slightly improving refining margins y-o-y, better Petchem prices, cost
cutting and increased marketing revenues due to increase in
domestic demand. HELPE’s
management will host a conference call at 18:00 (GR time) following the
release, to review the results.
Conference Call Details:
¡ Greece
Dial In +30 211 180 2000
¡
UK Dial In +44 (0) 800
368 1063
¡ US Dial
In +1 866 288 9315
Sarantis (H1/Q2 2014e group results
preview): We see a moderate Q2 profit growth recovery, +6% y-o-y to
€4.2m (vs -19% in 1Q14), on strong CE Europe
operations and a positive home sales momentum (+3%), thanks to a more benign
Greek consumer backdrop. Sarantis will publish its H1/Q2 2014 group results
today, post market close, and host a conference call the following day at
17:00 AST (Athens), 15:00 BST (London), 10:00 EST (New York).
Key points:
¡
We look for H1 2014 group sales, EBIT and
net profits of €120m (+4% y-o-y), €7.1m (-1% y-o-y), and
€6.1m (-3% y-o-y), respectively.
¡
In Q2 terms, group sales should advance 6%
y-o-y to €69m, driven by 3% home sales increase to €29m
(reversing trend vs 3% y-o-y drop in Q1 2014) and market share gains in CE
Europe.
¡
Tellingly, Greek April 2014 turnover index
in retail trade grew by 3.9% y-o-y (up 7.3% volume wise). This is may prove a
game changer, in our view, as it highlights the first positive growth in
retail sales since June 2010.
¡
Turning our focus to Sarantis
international operations, we forecast Q2 top-line up 8% y-o-y to €40m
(+9% y-o-y on constant exchange rates).
¡
In specific, we expect a sales growth of
9% y-o-y for both Poland and Romania to €20m and €10m,
respectively, accounting for 28% and 14% of group total in Q2 2014e.
¡
The group gross margin should remain resilient
in Q2, edging up 10bps to 50%, indicating product mix improvements as well as
better sourcing.
¡
We estimate Q2 group EBITDA 5% y-o-y
higher to €5.8m, despite seasonally increased marketing (promotional)
costs to boost demand for Sarantis products. As such, we forecast selling
expenses to rise 8% y-o-y to €27m (representing 38.5% of sales vs 38%
in Q2 2013).
¡
Going down the P&L, we forecast Q2
2014 group EBIT to advance 6% y-o-y to €4.9m against €4.6m a year
earlier.
¡
More particularly, we see domestic EBIT
marginally up by 1% y-o-y to €3.5m in Q2, on weakening margins (down
32bps to 12.1%).
¡
On the other hand, international
operations EBIT should rise 25% y-o-y to €1.4m (albeit from a low
base), triggered by higher margins (+47bps to 3.5%).
¡ In a
similar fashion, we expect Q2 2014e group EBT and a net earnings to post
increases of 5% and 6% y-o-y to €5.2m and €4.2m, respectively.
Conference Call Details
¡
GR +30 211 180 2000
¡
FR +33 (0) 170 918 711
¡
DE +49 (0) 69 2222 4493
¡
IT +39 06 452 36 748
¡
UK +44 (0) 800 368 1063
¡ US +1
866 288 9315
Alpha Trust-Andromeda (Results H1 2014): The fund
announced its net earnings for the first half of 2014 yesterday which came at
€0,590mn compared to a loss after tax of €0,017mn in the
corresponding period last year. The gross revenue of the Company reached €1,153mn, mostly
from portfolio positive valuation at fair value under IFRS.
Portfolio
performance was 5.22% since the beginning of the year, compared with
FTSE/ASE Large Cap 1.87%, FTSE/ASE MID CAP -2,98% and General Index
4.44%. At the end of H1 assets amounted to € 11.48 million, while
the Company's portfolio is invested 100% in Greece of which 91.92% in shares,
3.09% in bonds and 4.99% is cash. NAV at the end of the H1 was € 27.49
and the stock price of €22.40 trading at a discount of 18,52%. The
biggest portfolio stakes at the end of the first half were: Titan, OTE,
Inform Lykos, Plaisio Computers, Quest Holdings, OPAP, Thrace Plastics, PPA,
Alpha Bank And Mytilinaios.
0 σχόλια:
Δημοσίευση σχολίου
Ο σχολιασμός επιτρέπεται μόνο σε εγγεγραμμένους χρήστες